Claire Brown
InvestorPartner at Oxford Science Enterprises
Oxford, United Kingdom
Writes $100K β $5M checks Β· typically $1.5M
About
Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
Invests in
Biotech
Experience
- Oxford Science EnterprisesPartnercurrent2020 β presentOxford, England, United Kingdom
- Acionna TherapeuticsBoard of Directorscurrent2025 β present
- Scripta TherapeuticsBoard of Directorscurrent2025 β present
- Thelior BioBoard Directorcurrent2025 β present
- T-Cypher BioBoard Directorcurrent2021 β presentOxford, England, United Kingdom
- AlveoGeneBoard Directorcurrent2023 β present
- Orfonyx BioBoard Directorcurrent2022 β present
- Nucleome TherapeuticsBoard Observercurrent2023 β present
- OMass TherapeuticsBoard Observer2021 β 2024
- Dark Blue TherapeuticsBoard Director2020 β 2023Oxford, England, United Kingdom
- AlethiomicsBoard Director2022 β 2023
- Kinomica LimitedBoard Of Directors2019 β 2021London and Manchester, UK
- Pioneer GroupHead of Investment2015 β 2021Alderley Park
- NanoSyrinxBoard of Directors2020Warwick, England, United Kingdom
- Rinri Therapeutics Ltd.Board Of Directors2019 β 2020Sheffield, UK
- AstraZenecaDirector, Strategy, Business Development and Investment2007 β 2015UK
- Sanofi GenzymePrincipal Scientist, Pharmacology & Toxicology2004 β 2007USA
- UCB Research IncPharmacology Dept, Principal Scientist2000 β 2004
Education
- University of GlasgowBSc (Hons), Physiology
- Glasgow Caledonian UniversityPh.D, Pharmacology
- Loughborough UniversityMBA, Business Administration and Management
- CFA InstituteInvestment Management Certification2016
Skills & more
Drug Development9Life Sciences23Biotechnology21Drug Discovery15Pharmacology7R&D16
- Investment Management Certificate β CFA Institute
- Role of the Board β Institute of Directors (IoD)
From Claire's professional profile.
Same school
Also attended University of Glasgow38
Andreas SchropferHead of Finance at Brighteye VenturesKelsey BolanderAssociate β Business Ops & Partner Support at Energize VenturesRob DesboroughGeneral Partner and Chair of Seraphim Space Accelerator at Seraphim SpaceNatalie JohnstonInvestment Principal at 4BIO CapitalLydia KwonVP Partnerships at DWF LabsPhilippe de LathuyLegal Counsel at Astanor Ventures
+ 32 more
Also attended Glasgow Caledonian University5
Also attended Loughborough University44
Abbie RobusAssociate Director at Mayfair Equity PartnersDiane WalkerHead of Group Finance & Operations at Mayfair Equity PartnersCostanza CariniInvestor at DN CapitalAlasdair MitchellPortfolio Support at Giant Ventures Global LlpDiana KoziarskaManaging Partner at SMOK VenturesPetri LaineVenture Partner, Innovestor Venture Capital at Innovestor Ventures
+ 38 more
Shared employers
Also worked at Scripta Therapeutics4
Also worked at OMass Therapeutics2
Also worked at Kinomica Limited1
Also worked at AstraZeneca50
Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at Industrifonden
+ 44 more
Colleagues at Oxford Science Enterprises
Alex Hammacher
Head of Strategic Operations & Corporate Finance at Oxford Science Enterprises
Alexandra Riozzi
Executive Assistant at Oxford Science Enterprises
Alicia Mederick
Team Co-ordinator at Oxford Science Enterprises
Alma Simangunsong
People Apprentice at Oxford Science Enterprises
Andre Crawford-Brunt
Non-Executive Director at Oxford Science Enterprises
Andrew Straiton
Senior Associate, Deep Tech at Oxford Science Enterprises
Andy Penfold
Content Lead at Oxford Science Enterprises
Antonia Jenkinson
Chief Financial Officer at Oxford Science Enterprises
Network4
Lilly Bussmann
Partner at Oxford Science Enterprises
Martin Fiennes
Advisor, Deep Tech at Oxford Science Enterprises
Matthew Arnold
Principal at Oxford Science Enterprises
Nicholas Dixon-Clegg
Partner, Head of Independent Investments at Oxford Science Enterprises
Investors connected to Claire in public investor directories β a warm-intro map.






































